New risk gene discovery gives hope to early-onset breast cancer sufferers

October 24, 2013

A new breast cancer risk gene has been discovered which explains the early-onset breast cancer in some multiple-case breast cancer families.

The international team of investigators led by the University of Melbourne Australia, identified in the RINT1 gene to increase risk of breast and many other cancers.

Professor Melissa Southey and Dr Daniel Park from the University's Department of Pathology presented the research today at the American Society of Human Genetics 2013 annual meeting in Boston.

Other researchers in this international team are from the Institute Curie in Paris, the International Agency for Research on Cancer in Lyon, France, and the Huntsman Cancer Institute in Salt Lake City, Utah.

Professor Southey said "this discovery will assist some more women learn the genetic explanation for their breast cancer risk and which of their family members are at high risk of developing cancer.   Currently only about 35 per cent of the familial risk for breast cancer has been explained."

Co-researcher Dr Park, Senior Research Fellow said "although mutations in RINT1 are rare, it is most likely that the remaining unknown breast will account for similar small proportions of the disease."

Rare mutations in RINT1 were identified in three of 49 families participating in a multiple-case breast cancer family study. The study applied the latest technology to search for unidentified breast genes.  

The researchers then assessed the association between RINT1 mutations and by conducting a population-based case-control study that identified 23 mutation carriers in a sample of 1,313 women diagnosed with early-onset breast cancer and only 6 mutation carriers in 1,123 unaffected women, demonstrating a significant association between mutations in RINT1 and risk of early onset breast cancer.

Further research included testing an additional 684 affected women from multiple-case breast cancer families for RINT1 mutations and six additional families were found to carry in RINT1.

This demonstration of RINT1 as a cancer susceptibility gene is consistent with prior literature that has described mice that carry a rint1 mutation spontaneously develop a variety of tumors including breast cancer, at a combined rate of 81 per cent, higher than the rate at which spontaneously develops in laboratory mice that have a brca1 mutation.

Explore further: A new breast cancer susceptibility gene

Related Stories

A new breast cancer susceptibility gene

March 29, 2012

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not ...

Pill effects on breast, ovarian CA same in high-risk women

October 22, 2013

(HealthDay)—Among women who are BRCA1/2 mutation carriers, the associations between ever use of oral contraceptives (OCs) and ovarian and breast cancers are similar to those observed in the general population, according ...

Recommended for you

Malaria vaccine provides hope for a general cure for cancer

October 13, 2015

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim ...

Breast cancer drug beats superbug

October 13, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.